Satellos Bioscience(MSLE)
TORONTO, Ontario, CanadaBiotechnology
Focus: Satellos Bioscience is a publicly-traded Toronto-based biotech focused on stimulating the body's innate tissue repair and regeneration mechanisms using biologic and small molecule drugs, primarily in rare diseases. The company is pre-revenue and early-stage in clinical development.
Profile data last refreshed 16m ago · AI intelligence enriched 3w ago
Funding Stage
PUBLIC
Open Jobs
0
About Satellos Bioscience
AI assessmentNot HiringNo open roles listed right now. Follow Satellos Bioscience to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Satellos Bioscience's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
3 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
SAT-3247
Duchenne Muscular DystrophyClinical Trials (1)
NCT06565208First in Human SAD/MAD Safety and PK Study With Adult DMD Safety and PK Cohort
Phase 1Help build intelligence for Satellos Bioscience
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.